PSMD1 and thymic carcinoma: The correlation between clinical outcome and the expression of thymidine synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase, to which associated S‐1 activities in thymic carcinomas treated with S‐1 remains unclear.16